Literature DB >> 31121277

Therapeutic mRNA delivery to leukocytes.

Yasmin Granot-Matok1, Edo Kon1, Niels Dammes1, Gilad Mechtinger1, Dan Peer2.   

Abstract

In the past few years mRNA molecules have become an attractive class of new drugs with numerous opportunities. mRNA therapeutics holds great potential for the treatment of a variety of diseases and is an emerging field both in academia and in the pharma industry. Among the various mRNA-based therapeutic approaches, immunotherapy is one of the pioneering and most advanced therapy to date. Immune cells manipulation using mRNA is commonly used for vaccination purposes, but its potential is much broader. In this review, we discuss the promise of mRNA delivery to leukocytes. We aim to provide an overview of the main progress in this field, as well as the challenges in expanding the scope of mRNA therapy for different therapeutic applications. We also discuss the main technological developments for overcoming mRNA therapy limitations, including mRNA rational design and delivery platforms.
Copyright © 2019 Elsevier B.V. All rights reserved.

Year:  2019        PMID: 31121277     DOI: 10.1016/j.jconrel.2019.05.032

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  11 in total

Review 1.  mRNA-based therapeutics: powerful and versatile tools to combat diseases.

Authors:  Shugang Qin; Xiaoshan Tang; Yuting Chen; Kepan Chen; Na Fan; Wen Xiao; Qian Zheng; Guohong Li; Yuqing Teng; Min Wu; Xiangrong Song
Journal:  Signal Transduct Target Ther       Date:  2022-05-21

Review 2.  The Past, Present, and Future of Non-Viral CAR T Cells.

Authors:  Alex Moretti; Marianna Ponzo; Charles A Nicolette; Irina Y Tcherepanova; Andrea Biondi; Chiara F Magnani
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

Review 3.  Freeze-drying for the preservation of immunoengineering products.

Authors:  Nagavendra Kommineni; Arun Butreddy; Vaskuri G S Sainaga Jyothi; Pavimol Angsantikul
Journal:  iScience       Date:  2022-09-13

Review 4.  The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing.

Authors:  Parichehr Hassanzadeh
Journal:  Life Sci       Date:  2021-03-04       Impact factor: 6.780

5.  Intravesical delivery of KDM6A-mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer.

Authors:  Na Kong; Ruonan Zhang; Gongwei Wu; Xinbing Sui; Junqing Wang; Na Yoon Kim; Sara Blake; Diba De; Tian Xie; Yihai Cao; Wei Tao
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-15       Impact factor: 12.779

6.  A polyphenol-assisted IL-10 mRNA delivery system for ulcerative colitis.

Authors:  Zhejie Chen; Wei Hao; Caifang Gao; Yangyang Zhou; Chen Zhang; Jinming Zhang; Ruibing Wang; Yitao Wang; Shengpeng Wang
Journal:  Acta Pharm Sin B       Date:  2022-04-02       Impact factor: 14.903

7.  Long-term storage of lipid-like nanoparticles for mRNA delivery.

Authors:  Pengxuan Zhao; Xucheng Hou; Jingyue Yan; Shi Du; Yonger Xue; Wenqing Li; Guangya Xiang; Yizhou Dong
Journal:  Bioact Mater       Date:  2020-03-18

Review 8.  mRNA Vaccine Era-Mechanisms, Drug Platform and Clinical Prospection.

Authors:  Shuqin Xu; Kunpeng Yang; Rose Li; Lu Zhang
Journal:  Int J Mol Sci       Date:  2020-09-09       Impact factor: 5.923

Review 9.  mRNA, a Revolution in Biomedicine.

Authors:  Bruno Baptista; Rita Carapito; Nabila Laroui; Chantal Pichon; Fani Sousa
Journal:  Pharmaceutics       Date:  2021-12-05       Impact factor: 6.321

Review 10.  Delivery of mRNA for regulating functions of immune cells.

Authors:  Jia Shi; Meng-Wen Huang; Zi-Dong Lu; Xiao-Jiao Du; Song Shen; Cong-Fei Xu; Jun Wang
Journal:  J Control Release       Date:  2022-03-23       Impact factor: 11.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.